Development of synthetic biodegradable microparticulate vaccines: a roller coaster story.
Pål
P
Johansen
Julia M
JM
Martínez Gómez
Bruno
B
Gander
D000818:Animals; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D007073:Immunoglobulin E / Q000276:immunology; D019344:Lactic Acid / Q000008:administration & dosage*; D008863:Microspheres; D011100:Polyglycolic Acid / Q000008:administration & dosage*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000276:immunology
D011108:Polymers; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D007073:Immunoglobulin E